glp-1 egfr cut off receptor agonists in patients with chronic kidney disease and either overweight or obesity KDOQI Commentary on the KDIGO
Description
[DOI] [PubMed] [Google Scholar] 171.Nian M, Gu J, Irwin DM, Drucker DJ
M., Patrone C., Iverfeldt K., Sjholm
In mice, the enzyme neprilysin additionally rapidly degrades the metabolites, making GLP-1 difficult to measure in this species [189]
This, in turn, could raise costs for all patients
[RxSS data
